Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.

Candeliere GA, Glorieux FH, Prud'homme J, St-Arnaud R.

N Engl J Med. 1995 Jun 8;332(23):1546-51.

2.

Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions.

Kashima TG, Nishiyama T, Shimazu K, Shimazaki M, Kii I, Grigoriadis AE, Fukayama M, Kudo A.

Hum Pathol. 2009 Feb;40(2):226-37. doi: 10.1016/j.humpath.2008.07.008. Epub 2008 Sep 16.

PMID:
18799196
3.

Detection of c-fos expression in benign and malignant musculoskeletal lesions.

Weisstein JS, Majeska RJ, Klein MJ, Einhorn TA.

J Orthop Res. 2001 May;19(3):339-45.

4.

[Fibrous dysplasia. The clinico-therapeutic picture and new data on its etiology. A review of the literature].

Mandrioli S, Carinci F, Dallera V, Calura G.

Minerva Stomatol. 1998 Jan-Feb;47(1-2):37-44. Review. Italian.

PMID:
9578646
5.

Activating mutations of Gs protein in monostotic fibrous lesions of bone.

Alman BA, Greel DA, Wolfe HJ.

J Orthop Res. 1996 Mar;14(2):311-5.

PMID:
8648511
6.

Cellular and molecular basis of fibrous dysplasia.

Marie PJ.

Histol Histopathol. 2001 Jul;16(3):981-8. Review.

PMID:
11510989
7.

Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM.

N Engl J Med. 1991 Dec 12;325(24):1688-95.

8.

Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?

Hannon TS, Noonan K, Steinmetz R, Eugster EA, Levine MA, Pescovitz OH.

J Pediatr. 2003 May;142(5):532-8.

PMID:
12756386
9.

[Cellular and molecular biology of fibrous dysplasia].

Marie P.

Ann Pathol. 2001 Dec;21(6):489-98. Review. French.

PMID:
11910936
11.

Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.

Stanton RP, Hobson GM, Montgomery BE, Moses PA, Smith-Kirwin SM, Funanage VL.

J Bone Miner Res. 1999 Jul;14(7):1104-14.

12.

Fibrous dysplasia of bone and McCune-Albright syndrome.

Chapurlat RD, Orcel P.

Best Pract Res Clin Rheumatol. 2008 Mar;22(1):55-69. doi: 10.1016/j.berh.2007.11.004. Review.

PMID:
18328981
13.
14.

Upregulation of c-fos protooncogene expression in pagetic osteoclasts.

Hoyland J, Sharpe PT.

J Bone Miner Res. 1994 Aug;9(8):1191-4.

PMID:
7976501
15.

An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.

Shenker A, Weinstein LS, Sweet DE, Spiegel AM.

J Clin Endocrinol Metab. 1994 Sep;79(3):750-5.

PMID:
8077356
16.

Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone.

Okamoto S, Hisaoka M, Ushijima M, Nakahara S, Toyoshima S, Hashimoto H.

Virchows Arch. 2000 Aug;437(2):133-7.

PMID:
10993273
17.

Melatonin deficiency and fibrous dysplasia: might a relation exist?

Abdel-Wanis ME, Tsuchiya H.

Med Hypotheses. 2002 Nov;59(5):552-4.

PMID:
12376077
18.

Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.

Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S.

J Clin Invest. 1996 Jul 1;98(1):30-5.

19.

Primary hyperparathyroidism-associated polyostotic fibrous dysplasia: absence of McCune-Albright syndrome mutations.

Hammami MM, al-Zahrani A, Butt A, Vencer LJ, Hussain SS.

J Endocrinol Invest. 1997 Oct;20(9):552-8.

PMID:
9413810
20.

Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.

Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P.

Am J Pathol. 1997 Dec;151(6):1587-600.

Supplemental Content

Support Center